Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
471-482
Author(s):
E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis
Estrogen Receptors as Targets for Drug Development for Breast Cancer, Osteoporosis and Cardiovascular Diseases
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
483-499
Author(s):
Thresia Thomas, Michael A. Gallo and T. J. Thomas
Two-Domain Vascular Disruptive Agents in Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
501-509
Author(s):
Stanislaw Szala
The Relationship Between Oncogene Expression and Clinical Outcome in Endometrial Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
511-520
Author(s):
Noriyuki Takai, Tami Ueda, Masakazu Nishida, Kaei Nasu and Isao Miyakawa
TSC-22 (TGF-β Stimulated Clone-22): A Novel Molecular Target for Differentiation-Inducing Therapy in Salivary Gland Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
521-529
Author(s):
H. Kawamata, T. Fujimori and Y. Imai
Mammaglobin-Based Strategies for Treatment of Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
531-542
Author(s):
Peter S. Goedegebuure, Mark A. Watson, Carsten T. Viehl and Timothy P. Fleming
Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2817-2826
Author(s):
M. Schulz and M. Eggert
Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2851-2860
Author(s):
Frank O. Fackelmayer
Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2861-2889
Author(s):
Aniko Somogyvari-Vigh and Dora Reglodi
Combining Gene Therapy and Radiation Against Cancer
Journal:
Current Gene Therapy
Volume:
4
Page:
231-248
Author(s):
Daila S. Gridley and James M. Slater